Senior Vice President at United Imaging Inducted to the AIMBE College of Fellows
HOUSTON, April 1, 2025 /PRNewswire/ -- United Imaging, a global manufacturer of modern medical imaging technology, is proud to announce that Lingzhi (Lance) Hu, Ph.D., Senior Vice President and Chief Technology Officer of United Imaging Research at United Imaging, has been inducted into the 2025 Class of the AIMBE College of Fellows. Election to the AIMBE College of Fellows...
Peijia Medical collaborates with dsm-firmenich to create groundbreaking innovative medical device products
SUZHOU, China, April 1, 2025 /PRNewswire/ -- Today, April 1st, Peijia Medical Technology (Suzhou) Co., Ltd. held a strategic innovation cooperation signing ceremony and a press conference to announce the research and development achievements of polymer heart valves using ultra-high molecular weight polyethylene (UHMWPE) and thermoplastic polyurethane (TPU) from the Biomedical business of...
Dizal Announces DZD8586 and DZD6008 Presentations at 2025 ASCO Annual Meeting
SHANGHAI, April 1, 2025 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that results of its investigational drug candidates DZD8586 and DZD6008, have been selected for presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting,...
Fosun International Reports Total Revenue of RMB 192.14 Billion and Industrial Operation Profit of RMB 4.9 Billion in 2024
HONG KONG, April 1, 2025 /PRNewswire/ -- On 30 March 2025, Fosun International Limited (HKEX stock code: 00656) announced its annual results for the year 2024. During the period, the Group's total revenue reached RMB192.14 billion. Its four core subsidiaries – Yuyuan, Fosun Pharma, Fosun Insurance Portugal, and Fosun Tourism Group – generated a total revenue of RMB134.65 billion, accounting for...
SHL Medical opens new US$220 million manufacturing facility in the US to serve growing autoinjector market
ZUG, Switzerland, April 1, 2025 /PRNewswire/ -- SHL Medical, a global leader in the design, development, and manufacturing of advanced self-injection solutions, has officially inaugurated its new state-of-the-art manufacturing facility in North Charleston, South Carolina. This strategic expansion marks a significant milestone in the Swiss-based company's global growth, reinforcing its commitment to meeting the increasing worldwide demand for autoinjectors,...
PeptiGrowth Inc. is Launching a Novel Synthetic Peptide: KGF alternative peptide (FGFR2b agonist)
TOKYO, April 1, 2025 /PRNewswire/ -- PeptiGrowth Inc. (Headquarters: Chiyoda-ku, Tokyo, President: Junichiro Ishizuka) has successfully developed a novel synthetic peptide called "KGF alternative- peptide (FGFR2b agonist)" which is functionally equivalent to recombinant keratinocyte growth factor (KGF). This product will be on the market beginning April 2025. Development of Synthetic Peptide...
ECHO IQ SIGNS STRATEGIC PARTNERSHIP AND INTEGRATION AGREEMENTS WITH SCIMAGE AND MEDAXIOM TO EXPAND ECHOSOLV AS ACROSS 36 US CARDIOLOGY NETWORKS
EchoSolv AS will be fully integrated into ScImage's medical workflow platform, facilitating streamlined deployment within MedAxiom's hospital and cardiology networks. ScImage is a nationally recognised Cloud and integrated workflow management platform, with over 1,200 users, specialising in the collation of medical images and secure, real-time access to patient information for a broad client base across the US. MedAxiom is an American...
Merck Exercised the Option for the Global Rights of Abbisko Therapeutics’s Pimicotinib
SHANGHAI, April 1, 2025 /PRNewswire/ -- On April 1, 2025, Beijing Time, Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics") announced that Merck has exercised the global commercialization option for pimicotinib (ABSK021), with an option exercise fee of USD85.0 million, under the licensing agreement signed in December 2023. The development represents further deepening of the collaboration, underscoring the unwavering commitment and...
Healthcare Sector Faces Escalating Cybersecurity Risks Amid Digital Transformation
Advanced Security Solutions and Regulatory Compliance Key to Strengthening Resilience LONDON, April 1, 2025 /PRNewswire/ -- The digital transformation of healthcare is improving patient care and operational efficiency but has also exposed the sector to heightened cybersecurity threats. Ransomware attacks, data breaches, and unauthorised access to sensitive information have surged, making healthcare a prime target for cybercriminals. Frost &...
Luye Pharma’s Rivastigmine Twice Weekly Transdermal Patch Approved for Marketing in Japan for the Treatment of Alzheimer’s Dementia
TOKYO, March 31, 2025 /PRNewswire/ -- Luye Pharma Group today announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the Japanese Ministry of Health, Labour and Welfare as a new drug, indicated for suppression of progression of dementia symptoms in mild to moderate Alzheimer's disease. The product is to be marketed as Rivaluen®...
